Sympathoinhibitory and depressor effects of amlodipine in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 2, 2003, Pages 153-160

  Huang, Bing S ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Amlodipine; Dietary sodium; Dihydropyridines; Spontaneously hypertensive rats; Sympathetic nerve activity; Sympathoinhibition

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL L TYPE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ACTIVITY; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE;

AMLODIPINE; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; HEART RATE; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; RATS; RATS, INBRED SHR; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

EID: 0042303833     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200308000-00001     Document Type: Article

References (35)

1. Leenen FHH, Ruzicka M, Huang BS. Central sympathoinhibitory effects of calcium channel blockers. Curr Hypertens Rep. 2001;3:314-321.
2. Churchill PC. Cellular mechanisms of renin release. Clin Exp Hypertens A. 1988;10:1189-1202.
3. Eikenberg DC, Lokhandwala MF. Calcium antagonist and sympathetic neuroeffector function. J Auto Pharmacol. 1986;6:237-255.
4. 3H]nitrendipine to heart and brain membranes from normotensive and spontaneously hypertensive rats. Eur J Pharmacol. 1983;88:277-278.
5. Akaike N, Kostyuk PG, Osipchuk YV. Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurons. J Physiol. 1989;412:181-195.
6. Lipscombe D, Madison DV, Poenie M, et al. Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons. Proc Natl Acad Sci U S A. 1988;85:2398-2402.
7. Igelmund P, Zhao YQ, Heinemann U. Effects of T-type, L-type, P-type, and Q-type calcium channel blockers on stimulus-induced pre- and post-synaptic calcium fluxes in rat hippocampal slices. Exp Brain Res. 1996; 109:22-32.
8. 2+ influx. J Neurophysiol. 1995;73:2553-2557.
9. Fox AP, Nowycky MC, Tsien RW. Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurons. J Physiol. 1987;349:149-172.
10. Huang BS, Leenen FHH. Sympathoinhibitory effects of central nifedipine in spontaneously hypertensive rats on high versus regular sodium intake. Hypertens. 1999;33:32-35.
11. Murzenok PP, Huang BS, Leenen FHH. Sympatho-inhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertens. 2000;35:631-636.
12. Janicki PK, Siembab D, Paulo EA, et al. Single-dose kinetics of nifedipine in rat plasm and brain. Pharmacol. 1988;36:183-187.
13. Larkin JG, Thompson GG, Scobie G, et al. Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures. Epilepsia. 1992;33:760-769.
14. Huang BS, Murzenok PP, Leenen FHH. Sympathoinhibitory and depressor responses to chronic infusion of nifedipine in spontaneously hypertensive rats on high salt. J Cardiovasc Pharmacol. 2000;36:704-710.
15. van Zwieten P. The Pharmacological properties of lipophilic calcium antagonists. Blood Press Suppl. 1998;2:5-9.
16. Lemmer B. Genetic aspects of chronobiologic rhythms in cardiovascular disease. In: Zehender M, Breithartd G, Just H, eds. From Molecule to Men. Steinkopff/Springer; 2000:203-213.
17. Leenen FHH. Sympathoinhibitory and sympathoexcitatory effects of dihydropyridine calcium antagonists. In: Epstein M, ed. Calcium antagonists in clinical medicine 3/E. Philadelphia: Hanley and Belfus Inc.; 2002: 771-794.
18. De Champlain J, Karas M, Nguyen P, et al. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens. 1998;16:1357-1369.
19. Ligtenberg G, Blankestijn PJ, Oey PL, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999;340:1321-1328.
20. Calhoun DA, Zhu S. Pretreatment with enalapril blunts nicardipine-induced sympathetic activation in spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens. 1999;17:507-512.
21. Higuchi S, Takeshita T, Ito N, et al. Arterial pressure and heart rate responses to calcium channel blockers administered in the brainstem. Circ Res. 1985;57:244-251.
22. Laurent S, Girered X, Tsoukaris-Kupter D, et al. Opposite central cardiovascular effects of nifedipine and Bay K 8644 in anesthetized rats. Hypertension. 1987;9:132-138.
23. Huang BS, Yuan B, Leenen FHH. Chronic blockade of brain "ouabain" prevents sympathetic hyper-reactivity and impairment of acute baroreflex resetting in rats with congestive heart failure. Can J Physiol Pharmacol. 2000;78:45-53.
24. Bazil MK, Webb RL. Hemodynamic effects of amlodipine and benazepril in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1993;21: 405-411.
25. Dodd MG, Gardiner DG, Cater AJ, et al. The hemodynamic properties of amlodipine in anesthetized and conscious dogs: comparison with nitrendipine and influence of beta-adrenal blockade. Cardiovasc Drugs Ther. 1989;3:545-555.
26. Burges RA, Dodd MG, Gardiner DG. Pharmacologic profile of amlodipine. Am J Cardiol. 1989;64:101-181.
27. Tamada S, Sugimoto N, Uchida S, et al. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors. J Cardiovasc Pharmacol. 1994;23:466-472.
28. Uchida S, Yamada S, Nagai K, et al. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists. Life Sci. 1997;61:2083-2090.
29. Cox DS, Scott KR, Gao H, et al. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants. Pharm Sci. 2001;90:1540-1552.
30. Leenen FHH, Harmsen E, Yu H, et al. Effects of dietary sodium on central and peripheral ouabain-like activity in spontaneously hypertensive rats. Am J Physiol. 1993;264:H2051-H2055.
31. +-induced sympatho-excitation and hypertension. Hypertens. 2002;39(pt 2):557-561.
32. Sanchez del Pino MM, Hawkins RA, Peterson DR. Biochemical discrimination between luminal and abluminal enzyme and transport activity of the blood-brain barrier. J Biol Chem. 1995;270:14907-14912.
33. Grant DA, Abbott J, Janigro D. Understanding the physiology of the blood-brain barrier: in vitro models. NIPS. 1998;13:287-293.
34. Galletti F, Rutledge A, Triggle DJ. Dietary sodium intake: influence on calcium channels and urinary calcium excretion in spontaneously hypertensive rats. Biochem Pharmacol. 1991;261:H1397-H1401.
35. Fabi F, Chiavarelli M, Argiolas L, et al. Evidence for sympathetic neurotransmission through presynaptic N-type calcium channels in human saphenous vein. Br J Pharmacol. 1993;110:338-342.